Reduction in IV Associated Contamination
Reduction in Intraoperative Lumen Contamination of Standard 3-Way Open Lumen Stopcock Sets Through Use of a Novel, Passive Bundle
1 other identifier
interventional
594
1 country
1
Brief Summary
The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 29, 2011
CompletedFirst Posted
Study publicly available on registry
August 31, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedResults Posted
Study results publicly available
October 18, 2018
CompletedOctober 18, 2018
August 1, 2018
3 months
August 29, 2011
August 20, 2018
September 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of Bacterial IV Stopcock Lumen Contamination
The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens. Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed
48 hours
Secondary Outcomes (1)
Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination
Until positive, up to 5 days
Study Arms (2)
Control
NO INTERVENTIONControl arm using standard of care operating room procedures and equipment
Problem Solving Innovations (PSI) Experimental
EXPERIMENTALImplementation of the passive bundle including HubScrub and DocIt
Interventions
Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.
Eligibility Criteria
You may qualify if:
- Adult patient undergoing surgery or procedure in operating room
- Undergoing general anesthesia
You may not qualify if:
- Children (age \< 18 years)
- Lack of intravenous access
- failure of anesthesia provider to complete training on experimental device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dartmouth-Hitchcock Medical Centerlead
- PSI Medicalcollaborator
Study Sites (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Related Publications (4)
Loftus RW, Muffly MK, Brown JR, Beach ML, Koff MD, Corwin HL, Surgenor SD, Kirkland KB, Yeager MP. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg. 2011 Jan;112(1):98-105. doi: 10.1213/ANE.0b013e3181e7ce18. Epub 2010 Aug 4.
PMID: 20686007BACKGROUNDKoff MD, Loftus RW, Burchman CC, Schwartzman JD, Read ME, Henry ES, Beach ML. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a novel device. Anesthesiology. 2009 May;110(5):978-85. doi: 10.1097/ALN.0b013e3181a06ec3.
PMID: 19352154BACKGROUNDLoftus RW, Koff MD, Burchman CC, Schwartzman JD, Thorum V, Read ME, Wood TA, Beach ML. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008 Sep;109(3):399-407. doi: 10.1097/ALN.0b013e318182c855.
PMID: 18719437BACKGROUNDLoftus RW, Brindeiro BS, Kispert DP, Patel HM, Koff MD, Jensen JT, Dodds TM, Yeager MP, Ruoff KL, Gallagher JD, Beach ML, Brown JR. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg. 2012 Dec;115(6):1315-23. doi: 10.1213/ANE.0b013e31826d2aa4. Epub 2012 Nov 9.
PMID: 23144441RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Randy Loftus, MD
- Organization
- Dartmouth-Hitchcock Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Bryan S Brindeiro, MD
Dartmouth-Hitchcock Medical Center
- STUDY DIRECTOR
Randy W Loftus, MD
Dartmouth-Hitchcock Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2011
First Posted
August 31, 2011
Study Start
August 1, 2011
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
October 18, 2018
Results First Posted
October 18, 2018
Record last verified: 2018-08